BioPlus Acquisition Corp.

BioPlus Acquisition Corp. (Nasdaq: BIOS) was a blank-check special purpose acquisition company that filed its S-1 registration statement with the SEC on July 20, 2021, targeting the biotechnology and life sciences sector. Sponsored by BioPlus Sponsor LLC, the vehicle was structured to identify and merge with a growth-stage healthcare or biopharmaceutical business. The company completed its initial public offering in 2021, joining a crowded cohort of healthcare-focused SPACs that came to market during that period. Subscribers to SpacDesk can access the full filing history, sponsor background, deal timeline, and current status for BioPlus Acquisition Corp. and thousands of other SPAC vehicles — sign up at SpacDesk for comprehensive SPAC data.